CannabCo Pharmaceutical Corp. is thrilled to announce that one of the industry’s most potent cannabis strains was tested and found to contain 41 percent total measurable cannabinoid content. The strain has a cannabinoid count of 40.59 percent and a THC content of 35 percent, according to lab testing. Apart from its high THC concentration, the strain’s main distinguishing attribute is that it was created with Purecann™, CannabCo’s proprietary Odourless Cannabis™ technology.
When PurecannTM is used, the product is nearly odorless when smoked or stored, reducing the impact on those who are sensitive to the intense odor of cannabis. This is an industry first, according to the business, and a product that is desperately required in the marketplace.
About CannabCo Pharmaceutical Corp.
CannabCo Pharmaceutical Corp. is a Canadian based full service cannabis company with operations in Brampton, Ontario. The company has received its “Confirmation of Readiness” from Health Canada to become a licensed producer and is currently building out its pilot facility in the Brampton Area. The company currently has two primary technologies, Purecann™ for the growing of Odourless Cannabis™, and PHOENIX, and enhanced cultivation system featuring a hydroponic grow system with high productivity and significantly lower cost per gram than traditional grow
